Evidence map›Paper›PMID 40725810›Full record

ArticleJournal of clinical medicine2025

Catheter Ablation of Premature Ventricular Contractions from Right Ventricular Outflow Tract: Concept and Application of Very-High-Power, Very-Short-Duration as a First-Line Ablation Strategy.

Shaojie Chen, Ramin Ebrahimi, Piotr Futyma, Sebastian Graeger, Gozal Mirzayeva, Anna Neumann, Daniel Schneppe, Luiz Vinícius Sartori, Sarah Janschel, Márcio Galindo Kiuchi and 2 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shaojie ChenDepartment of Internal Medicine B (Cardiology, Angiology, Pneumology and Internal Intensive Care Medicine), University Medicine Greifswald, 17475 Greifswald, Germany.ORCID 0000-0002-7082-9573
Ramin EbrahimiDepartment of Internal Medicine B (Cardiology, Angiology, Pneumology and Internal Intensive Care Medicine), University Medicine Greifswald, 17475 Greifswald, Germany.
Piotr FutymaSt. Joseph's Heart Rhythm Center, University of Rzeszów, 35-310 Rzeszów, Poland.ORCID 0000-0003-0219-7612
Sebastian GraegerDepartment of Internal Medicine B (Cardiology, Angiology, Pneumology and Internal Intensive Care Medicine), University Medicine Greifswald, 17475 Greifswald, Germany.ORCID 0009-0008-4592-1096
Gozal MirzayevaDepartment of Internal Medicine B (Cardiology, Angiology, Pneumology and Internal Intensive Care Medicine), University Medicine Greifswald, 17475 Greifswald, Germany.
Anna NeumannDepartment of Internal Medicine B (Cardiology, Angiology, Pneumology and Internal Intensive Care Medicine), University Medicine Greifswald, 17475 Greifswald, Germany.
Daniel SchneppeDepartment of Internal Medicine B (Cardiology, Angiology, Pneumology and Internal Intensive Care Medicine), University Medicine Greifswald, 17475 Greifswald, Germany.ORCID 0000-0002-3965-041X
Luiz Vinícius SartoriDepartment of Internal Medicine B (Cardiology, Angiology, Pneumology and Internal Intensive Care Medicine), University Medicine Greifswald, 17475 Greifswald, Germany.
Sarah JanschelDepartment of Internal Medicine B (Cardiology, Angiology, Pneumology and Internal Intensive Care Medicine), University Medicine Greifswald, 17475 Greifswald, Germany.
Márcio Galindo KiuchiSchool of Medicine-Royal Perth Hospital Unit, University of Western Australia, Perth, WA 6009, Australia.ORCID 0000-0002-1155-8590
Martin MartinekDepartment for Internal Medicine II, Cardiology, Angiology, and Intensive Care, Akademisches Lehrkrankenhaus, Ordensklinikum Linz Elisabethinen, 4020 Linz, Austria.ORCID 0000-0002-8895-8488
Helmut PürerfellnerDepartment for Internal Medicine II, Cardiology, Angiology, and Intensive Care, Akademisches Lehrkrankenhaus, Ordensklinikum Linz Elisabethinen, 4020 Linz, Austria.ORCID 0000-0002-8965-8495

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This technical report presents a compelling case for the use of very-high-power, very-short-duration (VHPSD) radiofrequency ablation as a promising and efficient strategy for treating symptomatic premature ventricular contractions (PVCs) originating from the right ventricular outflow tract (RVOT). The patient with frequent, symptomatic PVCs and a 24% burden underwent successful ablation using a 90 W/4 s recipe via the QDOT MICRO™ catheter. The procedure resulted in immediate and sustained elimination of PVCs, with only 4 s of ablation time, near-zero fluoroscopy, no complications, and no PVC recurrence at 6 months. VHPSD ablation, though originally developed for atrial fibrillation, demonstrated remarkable procedural efficiency, precision, and lesion efficacy in this case. Compared to standard power, long-duration (SPLD) ablation, VHPSD offers the potential to significantly reduce procedural time, minimize tissue edema, and lower complication risk, particularly advantageous in anatomically challenging areas or in situations where maintaining stable catheter contact for extended periods is difficult or unfeasible. This technical report suggests the transformative potential of VHPSD as a first-line ablation strategy for RVOT-PVCs, provided careful mapping and appropriate technique are used. It underscores the need for further prospective studies to validate its broader safety, efficacy, and role in PVC management, particularly in cases involving intramural origins.

Indexed as

90 Wcatheter ablationpremature ventricular contractionsright ventricular outflow tractventricular arrhythmiavery-high-power–short-duration

Identifiers

PMID40725810
PMCPMC12295030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.